Praxis Precision Medicines Inc
PRAX
NASDAQ
Biotechnology
$366.81
USD
-1.65 (-0.45%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $10.29B
Volume 262.2K
Revenue
$0
TTM
-100.0%
YoY
Gross Margin
—
TTM
— YoY
Net Income
$-339.13M
TTM
-35.1%
YoY
Operating Cash Flow
$-305.08M
TTM
-59.5%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | -100.0% | -100.0% | -100.0% | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 13.1 | 12.6 | 19.5 | 27.9 | 27.5 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 76.1 | 78.4 | 97.0 | 105.9 | 96.9 |
Operating Income | -76.1 | -78.4 | -97.0 | -105.9 | -96.9 |
EBITDA | -76.0 | -78.3 | -97.0 | -105.8 | -96.9 |
Other Income / Expense | 4.9 | 4.4 | 8.1 | 13.3 | 13.2 |
Total Other Income / Expense | 4.9 | 4.4 | 8.1 | 13.3 | 13.2 |
Income Before Income Taxes | -71.1 | -73.9 | -88.9 | -92.6 | -83.7 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -71.1 | -73.9 | -88.9 | -92.6 | -83.7 |
Consolidated Net Income / Loss | -71.1 | -73.9 | -88.9 | -92.6 | -83.7 |
Net Income Attributable to Common Shareholders | -71.1 | -73.9 | -88.9 | -92.6 | -83.7 |
Basic EPS | -$3.31 | -$3.36 | -$3.49 | -$3.20 | -$2.87 |
Diluted EPS | -$3.31 | -$3.36 | -$3.49 | -$3.20 | -$2.87 |
Basic Shares Outstanding | 21.5M | 22.0M | 25.5M | 28.9M | 29.1M |
Diluted Shares Outstanding | 21.5M | 22.0M | 25.5M | 28.9M | 29.1M |